Mutations in the PTCH1 gene (encoding Patched-1 receptor) and the SMO gene (encoding the Smoothened homolog) lead to abnormal pathway activation, resulting in medulloblastoma and basal cell carcinoma. This evidence concerns the gene PTCH1 and basal cell carcinoma.